Clinical Trial

Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness and safety of tramadol and oxycodone therapy in comparison to oxycodone alone as part of a multimodal pain regimen to reduce postoperative opioid consumption, pain, minimize adverse events and complications for primary total knee arthroplasty (TKA) and primary total hip arthroplasty (THA).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-26; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-03-16
Trial Details
NCT Number NCT07153003
Lead Sponsor Mayo Clinic
Conditions Post Operative Pain
Enrollment 560 participants
Start Date 2026-02-02
Primary Completion 2030-09-01 (estimated)
Study Completion 2031-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18